Pfizer CFO to depart; GSK wins approval for UTI drug

June 18, 2026 10:54 AM EDT News Briefing Pfiz­er CFO to de­part; GSK wins ap­proval for UTI drug ENDPOINTS Plus news about Apel­lis Phar­ma­ceu­ti­cals, Servi­er, TORL Bio­Ther­a­peu­tics, Ve­rastem, Cor­cept Ther­a­peu­tics, Leg­end Biotech, COUR Phar­ma­ceu­ti­cals, cAMP­field Ther­a­peu­tics and Lab­Ge­nius Ther­a­peu­tics. 👋 Pfiz­er’s CFO will de­part … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER